Clinical Decision Support and Palivizumab: A Means to Protect from Respiratory Syncytial Virus.
Palivizumab can reduce hospitalizations due to respiratory syncytial virus (RSV), but many eligible infants fail to receive the full 5-dose series. The efficacy of clinical decision support (CDS) in fostering palivizumab receipt has not been studied. We sought a comprehensive solution for identifying eligible patients and addressing barriers to palivizumab administration.
Author(s): Utidjian, L H, Hogan, A, Michel, J, Localio, A R, Karavite, D, Song, L, Ramos, M J, Fiks, A G, Lorch, S, Grundmeier, R W
DOI: 10.4338/ACI-2015-08-RA-0096